Literature DB >> 15634344

Integrase of Mason-Pfizer monkey virus.

Jan Snásel1, Zdenek Krejcík, Vera Jencová, Ivan Rosenberg, Tomás Ruml, Jerry Alexandratos, Alla Gustchina, Iva Pichová.   

Abstract

The gene encoding an integrase of Mason-Pfizer monkey virus (M-PMV) is located at the 3'-end of the pol open reading frame. The M-PMV integrase has not been previously isolated and characterized. We have now cloned, expressed, isolated, and characterized M-PMV integrase and compared its activities and primary structure with those of HIV-1 and other retroviral integrases. M-PMV integrase prefers untranslated 3'-region-derived long-terminal repeat sequences in both the 3'-processing and the strand transfer activity assays. While the 3'-processing reaction catalyzed by M-PMV integrase was significantly increased in the presence of Mn(2+) and Co(2+) and was readily detectable in the presence of Mg(2+) and Ni(2+) cations, the strand transfer activity was strictly dependent only on Mn(2+). M-PMV integrase displays more relaxed substrate specificity than HIV-1 integrase, catalyzing the cleavage and the strand transfer of M-PMV and HIV-1 long-terminal repeat-derived substrates with similar efficiency. The structure-based sequence alignment of M-PMV, HIV-1, SIV, and ASV integrases predicted critical amino acids and motifs of M-PMV integrase for metal binding, interaction with nucleic acids, dimerization, protein structure maintenance and function, as well as for binding of human immunodeficiency virus type 1 and Rous avian sarcoma virus integrase inhibitors 5-CI-TEP, DHPTPB and Y-3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634344     DOI: 10.1111/j.1432-1033.2004.04386.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

1.  Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.

Authors:  Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

2.  Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors.

Authors:  Said A Hassounah; Thibault Mesplède; Peter K Quashie; Maureen Oliveira; Paul A Sandstrom; Mark A Wainberg
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 3.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

4.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

5.  Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents.

Authors:  Hiroaki Togami; Kazuya Shimura; Munehiro Okamoto; Rokusuke Yoshikawa; Takayuki Miyazawa; Masao Matsuoka
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

6.  Cross-packaging of genetically distinct mouse and primate retroviral RNAs.

Authors:  Noura Salem Al Dhaheri; Pretty Susan Phillip; Akela Ghazawi; Jahabar Ali; Elizabeth Beebi; Soumeya Ali Jaballah; Tahir A Rizvi
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

7.  The N-end rule and retroviral infection: no effect on integrase.

Authors:  Guney Boso; Takafumi Tasaki; Yong Tae Kwon; Nikunj V Somia
Journal:  Virol J       Date:  2013-07-13       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.